CHIP, which refers to the clonal expansion of white blood cells derived from a hematopoietic stem or progenitor cell that have acquired one or more somatic mutations (23), poses a unique challenge for NGS-based ctDNA assays since it can cause the apparent detection of tumor-associated somatic mutations in the plasma of healthy, aging individuals. This evidence concerns the gene STUB1 and neoplasm.